Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2012 Aug 31;287(44):37522–37529. doi: 10.1074/jbc.M112.384784

Mycobacterium tuberculosis Prokaryotic Ubiquitin-like Protein-deconjugating Enzyme Is an Unusual Aspartate Amidase*

Kristin E Burns ‡,1, Fiona E McAllister §,1, Carsten Schwerdtfeger , Julian Mintseris §, Francisca Cerda-Maira , Elke E Noens , Matthias Wilmanns , Stevan R Hubbard **, Francesco Melandri , Huib Ovaa ‡‡, Steven P Gygi §, K Heran Darwin ‡,2
PMCID: PMC3481346  PMID: 22942282

Background: Dop is critical for the full virulence of Mycobacterium tuberculosis; however, its mechanism is not understood.

Results: Asp-95 was identified as a catalytically significant residue.

Conclusion: This work suggests that Asp-95 functions either as a direct nucleophile forming a unique anhydride intermediate or is part of a catalytic center that includes polarized water as the nucleophile.

Significance: Understanding the mechanism of Dop can help guide the design and selection of inhibitors.

Keywords: Mycobacterium tuberculosis, Protease, Proteasome, Protein Deamidation, Protein Degradation, Pup, Depupylation

Abstract

Deamidase of Pup (Dop), the prokaryotic ubiquitin-like protein (Pup)-deconjugating enzyme, is critical for the full virulence of Mycobacterium tuberculosis and is unique to bacteria, providing an ideal target for the development of selective chemotherapies. We used a combination of genetics and chemical biology to characterize the mechanism of depupylation. We identified an aspartate as a potential nucleophile in the active site of Dop, suggesting a novel protease activity to target for inhibitor development.

Introduction

Proteasomes are protein complexes that degrade proteins that the cell has marked for destruction. The prokaryotic ubiquitin-like protein (Pup)3-proteasome pathway, present in Actinobacteria and Nitrospira, is critical for the virulence of Mycobacterium tuberculosis, the causative agent of tuberculosis and one of the world's deadliest pathogens. In this pathway, the protein Pup post-translationally modifies proteins for proteolysis by a bacterial proteasome complex in a manner analogous to the ubiquitin-proteasome system in eukaryotes (see Fig. 1A) (1). Pup is activated by the enzyme deamidase of Pup (Dop), which deamidates the C-terminal glutamine of Pup (PupGln) to form glutamate (PupGlu). Proteasome accessory factor A (PafA), the Pup ligase, subsequently ligates the newly formed side chain carboxylate to a lysine residue of the target protein (2). Pupylated proteins are guided into the proteasome through the binding of Pup to Mycobacterium proteasomal ATPase, which unfolds proteins prior to delivery into the proteasome core composed of 14 α- and 14 β-subunits (36). Dop also functions as a depupylase to remove Pup from substrate proteins prior to proteasomal destruction (79). These six proteins are the minimal requirement for a functional Pup-proteasome pathway in mycobacteria (5, 10).

FIGURE 1.

FIGURE 1.

A, pupylation pathway in mycobacteria. B, general strategy for the formation of the HA-Pup-DON trap. HA-tagged Pup was cloned in-frame with an intein domain fused to a chitin-binding domain (CBD), and the HA-PupΔGln was overproduced and bound to chitin resin. The bound protein was incubated with MeSNa, resulting in the elution of HA-Pup-MeSNa. Addition of DON to the reaction mixture displaced MeSNa and generated HA-Pup-DON. C, Dop immunoblot (IB) of the reaction with HA-Pup-DON and lysates of M. tuberculosis WT, dop, and dop-complemented strains. All strains contain the integrative plasmid pMV306 (empty vector) or pMV306 with WT dop or dopE10A at the attB site of the chromosome. In C and F, the asterisk indicates a species only seen in the dop:ΦMycoMarT7 mutant and is predicted to be truncated Dop. Samples were separated on a 9% SDS-PAGE gel. D, HA-Pup-DON reaction with purified Dop. Slowed migration of Mycobacterium smegmatis Dop (left) and Mycobacterium tuberculosis Dop (right) only occurred in the presence of HA-Pup-DON and ATP. Samples were separated on a 12% SDS-PAGE gel. Arrowhead indicates HA-Pup-DON∼Dop. The faster migrating species is specific to the Pup-DON trap as it was recognized alone by antibodies to the HA epitope (center lane). E, high resolution tandem mass spectrometry analysis of the HA-immunoprecipitated HA-Pup-DON∼Dop species indicating a modification of mass 257.1 Da on Asp-95 of Dop. F, Dop immunoblot of the reaction with HA-Pup-DON trap and lysates of M. tuberculosis WT, dop, and dop-complemented strains. Samples were separated on a 10% SDS-PAGE gel. G, proposed mechanism of HA-Pup-DON and Dop conjugation reaction. HA-Pup-DON is protonated in the active site of Dop, followed by a nucleophilic attack to displace nitrogen, and this results in the covalent HA-Pup-DON∼Dop adduct.

Despite the functional homology between the ubiquitin-proteasome system and the Pup-proteasome pathway, similarity at the protein level is limited. Most notably, Dop and PafA, which are similar to each other, have no sequence or structural homologues within the ubiquitin-proteasome system. Reports have highlighted the similarity of Dop and PafA to proteins of the glutamine synthetase-fold superfamily (9, 11), including Escherichia coli YbdK, a γ-glutamyl-cysteine synthetase. Mutagenesis and biochemical analyses demonstrated that PafA follows this γ-glutamyl-cysteine synthetase model, where the C-terminal γ-carboxylate of PupGlu is activated through phosphorylation by ATP and subsequently ligated to the ϵ-amino group of lysine residues on target proteins (12). Despite the predicted structural homology to the glutamine synthetase/γ-glutamyl-cysteine synthetase-fold superfamily of proteins and to PafA, the mechanism of the Dop amidase activity remains unclear. Unlike PafA and other glutamine synthetase-fold proteins, Dop requires ATP binding, but not hydrolysis, suggesting that ATP is a co-factor (2, 7, 8). Additionally, protease inhibitors such as PMSF or iodoacetamide did not inhibit Dop (supplemental Fig. S1). Based on a structural model of Dop, we identified several residues that are critical for Dop activity (9). Although the model provided some insight into the active site of Dop, no obvious catalytic motif emerged.

Because Dop is critical for the full virulence of M. tuberculosis in vivo, and it is unique to bacteria, it provides a potentially ideal target for the development of selective chemotherapies against M. tuberculosis. Understanding how Dop cleaves the amide bond at the C terminus of Pup is necessary for the development and optimization of inhibitors to be used as drug candidates. Here, we have elucidated the mechanism of Dop activity using a substrate analogue trap along with genetic and chemical biology approaches.

EXPERIMENTAL PROCEDURES

Molecular Biology

Bacterial strains and plasmids used in this study are listed in supplemental Table S1. E. coli strains used for cloning and expression were grown in LB broth (Difco) or LB agar at 37 °C. Mycobacterium smegmatis strains were grown in Middlebrook 7H9 broth (Difco) supplemented with 0.2% glycerol and 0.05% Tween 80. Cultures were grown at 37 °C with aeration on an orbital shaker. M. tuberculosis cultures were grown in Middlebrook 7H9 broth (Difco) supplemented with 0.2% glycerol, 0.05% Tween 80, 0.5% bovine serum albumin, 0.2% dextrose, and 0.085% sodium chloride. M. tuberculosis cultures were grown without shaking in 75-cm2 vented flasks (Corning, Tewksbury MA) at 37 °C. Mycobacteria were transformed as described elsewhere (13). Antibiotics were used at the following concentrations: hygromycin, 150 μg/ml (E. coli), 50 μg/ml (M. smegmatis and M. tuberculosis); kanamycin, 25 μg/ml (M. tuberculosis).

Plasmids and primers used in this study are listed in supplemental Table S1. M. tuberculosis dop-his6 was used for in vitro depupylase assays and trapping assay. Pup∼Ino1 was purified as described previously (14). pMV-dopE10A and pMV-dopD95N complementation plasmids were described previously (9), and the dop serine to alanine and threonine to alanine mutations were constructed similarly by sewing overlap extension PCR. M. tuberculosis pupGlu was cloned into the Nde1/HindIII site of pET24b(+) using the T7 forward and pupggerhind3 primers and using pET24b(+)-his6-pup (1) as a template to form pET24b(+)-pupGlu. Pup was amplified using primers Nde-HA-Pup-f and pup-ΔGQ-r. pTYB2-pupΔGln was generated by ligation of the fragment with pTYB2. pOLYG-Ms mdop-hispup) was used as described previously (8). All plasmids were sequenced by GENEWIZ, Inc. (South Plainfield, NJ).

Immunoblotting

Total cell lysates were prepared as described elsewhere in detail (8). Samples were separated by SDS-PAGE. HA antibodies (Sigma-Aldrich), Pup monoclonal (mouse) and polyclonal (rabbit) antibodies, and Dop antibodies are described elsewhere (1, 8). Horseradish peroxidase-coupled anti-rabbit or anti-mouse secondary antibodies were used according to the manufacturer's instructions (GE Healthcare). Detection of horseradish peroxidase was performed using either SuperSignal West Pico or West Femto Chemiluminescent Substrate (Thermo Scientific).

Dop and Pup∼Ino1 Purification

Dop-His6 and Pup∼Ino1-His6 were purified essentially as described previously (8), except we used a M. smegmatis strain with a C-terminal deletion in GroEL1 (15). This deletion removes a polyhistidine sequence in GroEL1, which eliminates co-purification of GroEL1 with target proteins.

M. tuberculosis Lysate Preparation for Trapping Reactions

M. tuberculosis was grown to an A580∼1 after which 50 A580 equivalent cell numbers were harvested and washed with 25 ml of 0.05% Tween 80 in PBS. The cells were resuspended in 1 ml of 50 mm Tris, pH 8, 50 mm NaCl and transferred to bead-beating tubes with 250 μl of zirconia silica beads. Cells were lysed by bead beating three times for 30 s. Lysates were filtered through 0.45-μm filters, glycerol was added to 12% final, and the samples were stored at −20 °C until further use.

HA-Pup-6-diazo-5-oxo-l-norleucine (DON) Formation, Trapping Reactions, and Mass Spectrometry Analysis

To produce HA-Pup-intein, 6 liters of LB was inoculated with 20 ml of an overnight culture of EHD853 and was grown at 37 °C until A600 = 0.49. The temperature was reduced to 18 °C before inducing with 0.5 mm isopropyl 1-thio-β-d-galactopyranoside and was grown overnight at 18 °C. The cells were harvested and resuspended in 350 ml of lysis buffer (50 mm MOPS, pH 6.5, 500 mm NaCl, 100 mm sodium acetate, 1 mm PMSF, and 2.5 μg/ml DNase), homogenized (15 min), and microfluidized three times. The soluble fraction was collected by centrifugation at 4 °C, and 0.1% Triton X-100 was added to the clarified lysate, followed by stirring for 60 min at 4 °C. The sample was centrifuged at 4 °C for 30 min and filtered through a 0.45-μm filter. 50-ml chitin resin (New England Biolabs, Ipswich, MA) was equilibrated in binding buffer (50 mm MOPS, pH 6.5, 500 mm NaCl, 100 mm sodium acetate, and 0.1% Triton X-100), and the soluble lysate was applied slowly and allowed to stir for 60 min at 4 °C. The resin-lysate mixture was applied to a gravity-flow column. The column was washed with 4 column volumes of binding buffer, 2 column volumes of wash buffer II (50 mm MOPS, pH 6.5, 150 mm NaCl, and 100 mm sodium acetate), and 2 column volumes of wash buffer III (50 mm MOPS, pH 6.5, and 100 mm sodium acetate). Following the washes, 75 ml of MeSNa buffer (50 mm MOPS, pH 6.5, 100 mm sodium acetate, and 100 mm 2-mercaptoethane sulfonate) (Fluka) was added, sealed with Parafilm, and incubated overnight at 37 °C, after which 100 ml was eluted from the column. Wash buffer III (50 ml) was applied to the column and collected, and this was repeated two more times for a total elution of 250 ml. The sample was concentrated to 10 ml using a 3,000-molecular weight cut-off membrane. Eluate was centrifuged, and supernatant was filtered through a 0.45-μm filter. The yield was about 1.8 mg/liter, and ∼80% of intact HA-Pup-MeSNa resulted, with the major contaminant being hydrolyzed HA-Pup.

Eluted HA-Pup-MeSNa (75 μm in 50 mm MOPS, pH 6.5, 100 mm sodium acetate, and 150 mm NaCl) was combined with 25 mm DON (Sigma) and 25 mm N-hydroxysuccinimide (Fluka) in 225 mm HEPES, pH 8.5, at room temperature for 18 h. The sample was extensively dialyzed against 50 mm MOPS, pH 6.5, 100 mm sodium acetate, and 150 mm NaCl. The product was diluted, and mass spectrometry analysis revealed labeled product HA-Pup-DON formed at ∼20% yield (∼15 μm HA-Pup-DON per reaction).

For trapping reactions with M. tuberculosis lysates, 42 μl of lysate, 6 μl of HA-Pup-DON (∼15 μm), 4.8 mm ATP, 5 mm MgCl2, 1.2 mm DTT, and 50 mm NaCl in 50 mm Tris, pH 8 were mixed in a final volume of 50 μl at room temperature. At 2 h, SDS loading buffer was added, and samples were analyzed by 9% SDS-PAGE. For purified Dop trapping assays, 2.1 μg of M. tuberculosis Dop-His6 or 7 μg of M. smegmatis Dop-His6-Pup, 3 μl of HA-Pup-DON (∼15 μm), 2 mm ATP, 3 mm MgCl2, 1 mm DTT, and 50 mm NaCl in 50 mm Tris, pH 8, were mixed in a final volume of 25 μl at room temperature. At 2 h, SDS loading buffer was added, and samples were analyzed by 12% SDS-PAGE.

For immunoprecipitation of the HA-Pup-DON-Dop complex, 75 μg of M. smegmatis Dop-His6-Pup, 60 μl of HA-Pup-DON (∼15 μm), 2 mm ATP, and 10 mm MgCl2 in 50 mm Tris, pH 8, were added in a final volume of 500 μl at room temperature. At 2 h, 1 ml of HA-agarose (Sigma-Aldrich), prewashed in NET buffer (5 mm EDTA, 150 mm NaCl, 0.5% Nonidet P-40 in 50 mm Tris, pH 8), was added, and the sample was brought to 10 ml with NET buffer. The sample was incubated overnight at 4 °C, washed three times with 10 ml of NET buffer, and eluted with the addition of SDS loading buffer and boiling. The sample was reduced with DTT (5 mm, 56 °C, 30 min), and the resulting free sulfhydryl groups alkylated with iodoacetamide (25 mm, 25 °C, 45 min) in the dark, quenched with DTT (10 mm), and then run on 4–12% SDS-PAGE gels, excised, in-gel digested with trypsin, and analyzed using LC-MS/MS using higher energy C-trap dissociation (HCD) fragmentation. To investigate the presence of possible PTMs, a large precursor mass tolerance search window of 300 Da (compared with the standard 50-ppm search window) was used to include hits from unknown PTMs. Possible PTM masses were identified by comparing the theoretical mass of high scoring peptides with the observed mass. Following identification of possible PTM masses, searches with a smaller precursor mass tolerance (50 ppm) were performed for the PTMs on the amino acids aspartate, glutamate, serine, threonine, and tyrosine that could act as nucleophiles. High resolution MS/MS spectra were additionally inspected by eye to assess the quality and correct assignment of the possible PTMs.

H218O Reactions and Mass Spectrometry Analysis

For 18O-water assays, reactions contained 4 μg of M. smegmatis Dop-His6-Pup, 22.5 μg of Pup∼Ino1, 2.5 mm ATP, 20 mm MgCl2, 1 mm DTT, and 50 mm NaCl in 50 mm Tris, pH 8, in a final volume of 250 μl, containing (or not for control) 50% 18O-water (Cambridge Isotope Laboratories, Andover, MA). After 3 h at 37 °C, 1 ml of cold acetone was added, and the sample was allowed to precipitate overnight at −20 °C. Protein was collected by centrifugation for 15 min in the cold, the pellet was air dried, SDS loading buffer was added, and the samples were analyzed by 15% SDS-PAGE.

For mass spectrometric analysis, Pup and Dop bands were excised from the gel and in-gel digested as described above but with the following modifications. Asp-N (Roche Applied Science) was used for the digestion of Pup, whereas trypsin was used for the digestion of Dop. The data were collected on an LTQ Orbitrap Velos (Thermo Scientific), and HCD fragmentation was used instead of collision-induced dissociation. A TOP10 method was used where one full MS scan was followed by up to 10 HCD MS/MS scans with an AGC setting of 3 × 104 and a maximum ion accumulation time of 250 ms. The normalized collision energy was set to 35%, with a resolution setting for detection of the HCD fragmentation ions of 7.5 × 103. For searching the HCD fragmentation spectra, the fragment ion tolerance was set to 0.02 Da. Otherwise, the settings were as described for the MS analysis of the hydroxylamine-treated samples using collision-induced dissociation fragmentation (see below).

Hydroxylamine Reactions

For hydroxylamine assays, reactions contained 5 μg of Dop-His6, 35 μg of Pup∼Ino1 (or 2.5 μg of PupGlu), 2.5 mm ATP, 20 mm MgCl2, 1 mm DTT, 100 mm hydroxylamine hydrochloride (made fresh at pH 6.5) (Sigma-Aldrich), and 50 mm NaCl in 50 mm Tris, pH 8, in a final volume of 50 μl at 37 °C. At the indicated times, samples were withdrawn and added to SDS loading buffer. Samples were analyzed by 16% SDS-PAGE and immunoblotting as described above.

Sample Preparation and Data Analysis for LC-MS/MS of Pup 1 and Pup 2

Bands were excised from the gel and cut into cubes of ∼1 mm and transferred into 1.5-ml Eppendorf tubes. In-gel digestion was done as described previously (16) except 100 ng of endoproteinase Asp-N was used for the digestion of the proteins in each band instead of trypsin. After digestion overnight, peptides were purified using Stage Tips (17), dried by vacuum centrifugation, and resuspended in 8 μl of 5% formic acid in glass inserts. 4 μl of each reaction was shot on an LTQ Orbitrap Elite mass spectrometer coupled to an Agilent 1200 series binary pump (Thermo Fisher Scientific). The peptides were loaded onto a hand-pulled fused silica microcapillary (125 μm × 15 cm, packed with Magic C18AQ, Michrom Bioresources, Auburn, CA) using a Famos autosampler (LC Packings, San Francisco, CA). Once loaded, the peptides were separated across a 23-min linear gradient of 6–33% solvent B (0.15% formic acid and 100% acetonitrile). Solvent A comprised 0.15% formic acid and 5% acetonitrile. Data were collected in a data-dependent mode using the TOP20 strategy (17). In each cycle, one full high resolution MS scan (resolution: 60,000) in the Orbitrap was followed by up to 20 MS/MS scans in the LTQ for the most intense ions at a 106 Automatic Gain Control target for full MS and a 2 × 103 AGC target for MS/MS, with a 500-minimum signal threshold and an isolation width of 2 Da. Dynamic exclusion of selected ions was set to 20 s (±10 ppm relative to the precursor ion m/z), and ions assigned a charge state of 1+ or those of unassigned charge were rejected. Full MS spectra were collected from 300 to 1,500 m/z. The maximum ion accumulation times were set to 1,000 ms and 150 ms for full MS and MS/MS scans, respectively. The normalized collision energy was set to 35% and activation time to 10 ms. Collision-induced dissociation was used for fragmentation. The data were collected in centroid mode.

RAW files were converted to mzXML files using the program ReAdW. MS/MS spectra were searched using the SEQUEST search algorithm (version 28) from the TB Database project in September 2010 using a mass tolerance of 2 Da. The search parameters for post-translational modifications included dynamic modifications of 15.99 Da on methionine (oxidation) and glutamine as well as deamidation on glutamine of 0.98 Da. Protein hits were filtered at the peptide and protein level to contain <1% false positives, estimated by the number of decoy hits using in-house software using linear discriminate analysis based on Xcorr, ΔCn, precursor mass error and charge state, as described previously (18).

RESULTS

Pup-DON Trap Reveals an Aspartate as a Potential Dop Nucleophile

In the absence of a conserved catalytic motif in Dop, we used an approach similar to that used in the ubiquitin field to identify deubiquitinases (19, 20). Previous studies used intein-based chemistry to add electrophilic moieties such as vinyl methyl ester to the C terminus of ubiquitin to covalently trap nucleophilic cysteines in deubiquitinases. Because Dop has glutamine deamidase activity, we modified Pup with DON, a glutamine mimic produced by Streptomyces (21) that has been used to identify nucleophilic residues in glutamine-hydrolyzing enzymes (22, 23). DON did not inhibit Dop-dependent amidohydrolysis in vitro (supplemental Fig. S2A); however, because Dop binds to Pup tightly (8), we attached DON to the C terminus of Pup to help deliver it to the active site. HA-tagged Pup, lacking its C-terminal glutamine, was produced as an intein-chitin-binding domain fusion protein, purified using chitin resin, and eluted with MeSNa to form HA-Pup-MeSNa. Addition of DON to HA-Pup-MeSNa replaced the MeSNa moiety with DON, forming the HA-Pup-DON substrate analogue (Fig. 1B and supplemental Fig. S2B).

We first tested labeling using HA-Pup-DON in lysates of several M. tuberculosis strains. All lysates showed a HA-Pup-DON-dependent shift of Dop migration by about 15 kDa, with the exception of lysates of a dop-null mutant and the dop mutant complemented with an inactive dop allele (dopE10A) (9) (Fig. 1C). We next tested the reaction of HA-Pup-DON with purified Dop. Dop from M. tuberculosis and M. smegmatis also exhibited a HA-Pup-DON-dependent shift of 15 kDa. This 15-kDa shift was dependent on ATP and reacted with antibodies to the HA tag, suggesting that the HA-Pup-DON trap was responsible for the shift in Dop migration (Fig. 1D). HA-Pup-MeSNa or hydrolyzed trap (HA-Pup-OH) did not label Dop (supplemental Fig. S2C).

To identify the residue that was labeled with HA-Pup-DON, we purified the HA-Pup-DON-Dop complex for analysis by MS. A PTM with the mass of 257.1 Da (corresponding to C10H15N3O5) was identified attached to Asp-95 (Fig. 1E). Among several residues in the proposed active site of Dop, Asp-95 is needed for Dop function in vivo (9), and mutation of this residue to asparagine abolished labeling by HA-Pup-DON (Fig. 1F). Following Dop-catalyzed protonation of the diazo-ketone moiety, we propose that Asp-95 acts as a nucleophile and displaces nitrogen, resulting in the HA-Pup-DON-Dop complex (Fig. 1G).

Site-directed Mutagenesis Eliminates Other Potential Nucleophiles

To gain further insight into the mechanism and potential role of Asp-95 as a nucleophile, we revisited the Dop active site model, which was reported previously (9). This model is based on limited structural homology to YbdK, a glutamine synthetase-fold enzyme, and accounts for residues 5–273 of M. tuberculosis Dop, including several important catalytic residues (9, 24). In the model, lysine is conjugated to the C-terminal glutamate of Pup via an isopeptide bond, reminiscent of the native Pup∼protein conjugate (Fig. 2A). Pup is anchored in the active site by Arg-206, and an analogous arginine is present in YbdK and in the PafA model for anchoring of the substrate carboxylate (9). According to the model, Asp-95 is well positioned for nucleophilic attack on the Pup∼Lys conjugate; however, to rule out the possibility that Dop uses another nucleophile for catalysis and a side reaction with HA-Pup-DON caused labeling of Asp-95, we mutated all conserved cysteine, serine, and threonine residues in Dop. When we compared M. tuberculosis Dop with PafA and Dop homologues from nine bacterial species, we found no conserved cysteines, four conserved serines (Ser-27, Ser-102, Ser-204, and Ser-295), and two conserved threonines (Thr-218 and Thr-262) (supplemental Fig. S3). Mutagenesis of the serines to alanines did not affect pupylation in M. tuberculosis (Fig. 2B). Mutagenesis of Dop Thr-262 reduced, but did not abolish, pupylation in vivo (Fig. 2B, compare first and last lanes). Although DopT262A stability was not affected, it is possible that Dop binding to certain substrates or Pup was impacted. Mutagenesis of Thr-218 resulted in normal pupylation (Fig. 2B). Collectively, these data suggest that neither serine nor threonine is critical for catalysis (Fig. 2B).

FIGURE 2.

FIGURE 2.

A, proposed model of the Dop active site, based on the crystal structure of E. coli YbdK (PDB code 1R8G) (24). Dop is colored green, and select side chains are shown in stick representation. Two Mg2+ ions (from PDB code 1VA6 (γ-glutamyl-cysteine synthetase)) are shown as magenta spheres. Oxygen atoms are colored red, and nitrogen atoms are colored blue. ADP is shown in stick representation with carbon atoms colored yellow and phosphorus atoms colored gray. The modeled Pup∼substrate (Lys) is colored orange (carbon atoms) with the terminal glutamate and conjugated lysine shown in stick representation. B, mutational analysis of potential Dop nucleophiles. Total cell lysates from equivalent cell numbers of a M. tuberculosis dop mutant strain containing integrated empty vector or plasmids encoding either wild type (WT) or mutated dop alleles were separated on a 10% SDS-PAGE gel and analyzed for pupylation by immunoblotting (IB) with monoclonal antibodies to M. tuberculosis Pup. The membrane was stripped and incubated with antibodies to Dop (below).

Evidence of an Anhydride Intermediate

Unable to pinpoint an alternative explanation for the labeling of Asp-95, we sought to gather more evidence of Asp-95 as a nucleophile. If Dop uses Asp-95 as a nucleophile, an anhydride intermediate would form; resolution of this intermediate with water hydrolysis yields the products. In 18O-water, an anhydride intermediate allows for a 50% chance that 18O-label will incorporate into Dop when the reaction proceeds. When Dop was incubated with the model pupylated substrate Pup∼Ino1 (inositol-1-phosphate synthetase) in the presence of 18O-water, we observed 18O-water incorporation into the C terminus of Pup and not Dop (Fig. 3, A and B, and supplemental Fig. S4). Additionally, we did not observe double 18O-incorporation into Pup, suggesting that Dop does not perform futile rounds of hydrolysis. The 18O-labeling results neither supported nor refuted the carboxylate nucleophile mechanism.

FIGURE 3.

FIGURE 3.

18O-Incorporation by mass spectrometry. The Dop-catalyzed Pup∼Ino1 depupylation reaction was monitored in the presence of 50% 18O-water, showing a shift in the isotopic distribution of the C-terminal PupGlu peptide corresponding to 18O-incorporation. B, 18O-incorporation not identified on Dop. C, Dop reaction with hydroxylamine. Chitin-binding domain is stained with 16% SDS-PAGE of the Pup∼Ino1 depupylation reaction: (left) in the absence of hydroxylamine; (center) in the presence of hydroxylamine; and (right) in the presence of hydroxylamine without ATP. Middle panel, enhanced image of the 10–12-kDa region of the gel above. Bottom, Pup IB of the two species formed upon addition of hydroxylamine is shown. D, PupGlu after incubation with hydroxylamine. Chitin-binding domain is stained with 16% SDS-PAGE of Pup reaction with Dop: (left) in the absence of hydroxylamine; (center) in the presence of hydroxylamine; and (right) in the presence of hydroxylamine without Dop. Note that this panel was enhanced to view all possible Pup species. E, Pup-hydroxymate (Pup-NHOH). LC chromatogram of the Pup 1 and Pup 2 species (labeled in C) is shown. Inset, presumed structure of Pup-NHOH. F, proposed mechanism of the Dop-catalyzed deconjugation reactions. The aspartate nucleophile attacks the Pup∼substrate amide, forming an anhydride intermediate. Base-catalyzed deprotonation of a water molecule activates it to attack at the Pup side of the anhydride to form the products.

Another method used to identify an anhydride intermediate is to trap it with a potent nucleophile. Hydroxylamine (NH2OH) has been used successfully to trap acyl-enzyme intermediates (2630), thus we decided to monitor the Dop-catalyzed depupylation reaction in the presence of hydroxylamine. Upon addition of hydroxylamine to the depupylation reaction with the substrate Pup∼Ino1, we observed the formation of two species of Pup by Coomassie Brilliant Blue staining and immunoblotting with antibodies specific to Pup (Fig. 3C, center lanes). The slower migrating species depended on ATP, Dop, and Pup∼Ino1, as preincubation of hydroxylamine with Dop or Pup∼Ino1, followed by removal of hydroxylamine, did not produce this species (supplemental Fig. S5). Additionally, the slower migrating Pup species did not form upon incubation of Dop with PupGlu and hydroxylamine (Fig. 3D). Mass spectrometry revealed this species to be Pup-hydroxymate (Pup-NHOH) (Fig. 3E and supplemental Fig. S6), suggesting that Dop produced an activated carbonyl during the course of the reaction. This activated carbonyl is not formed using the typical nucleophiles cysteine, serine, or threonine, as our mutagenesis data have ruled out these candidates (Fig. 2B).

DISCUSSION

Collectively, our data suggest that Dop uses Asp-95 as a nucleophile. Whereas aspartate and glutamate are nucleophiles for glycosidases, dehalogenases, and phosphatases (3133), to our knowledge, no known amidase uses aspartate as a nucleophile. There was controversy over whether an anhydride intermediate was formed with carboxypeptidase (3439); at low temperatures and with various substrate analogues, an anhydride was detected (34, 36, 39). However, this intermediate has not been trapped, and other evidence suggests carboxypeptidase acts as a metalloprotease. For Dop, we used an electrophilic trap that reacted with Asp-95, we used site-directed mutagenesis to eliminate other potential nucleophiles, and we provided support for a nucleophilic mechanism by resolving the proposed anhydride intermediate using hydroxylamine and visualizing Pup-hydroxymate.

Although it is possible that hydroxylamine acted as an alternate nucleophile in place of water for the direct attack of substrate and because we have yet to detect directly the proposed anhydride intermediate, we cannot rule out that Dop catalysis proceeds by a different mechanism. For example, it is possible that His-96, which is critical for Dop activity in vivo (9), is conserved in all Dop orthologues and is absent from PafA and YbdK, could be important for positioning Asp-95 in Dop for base-catalyzed deprotonation of water (Fig. 2A). This could also explain the labeling of Asp-95 with the HA-Pup-DON trap (Fig. 1). Furthermore, although Dop does not have characteristics typical of aspartate proteases, which use two aspartates to deprotonate water and typically have acidic pH optimum, the Dop model suggests a resemblance to aspartate proteases. According to the model, we could envision Asp-95 and Glu-10 acting similarly to an aspartate dyad to activate water for attack of the Pup∼lysine conjugate. Glu-10 is critical for the activity of Dop and its counterparts (nonproteolytic PafA and glutamine synthetase/γ-glutamyl-cysteine synthetase proteins) in vivo and in vitro (8, 9, 25); however, Glu-10 is predicted to coordinate Mg2+ and ATP and not play a direct role in catalysis (11). Finally, we cannot rule out the possibility that Dop uses a different residue as a nucleophile, one that we did not test. These include lysine or the terminal amino group.

Based on our data, however, we propose that Asp-95 attacks the γ-carbonyl side chain amide bond at the C terminus of PupGln or Pup attached to a substrate to form an anhydride intermediate (Fig. 3F). In the second step of the reaction, a base in Dop would activate water for attack at the Pup side of the anhydride, resolving the intermediate to form PupGlu and, in the case of the depupylation reaction, the unmodified substrate.

Dop has at least two roles in the Pup-proteasome pathway: (a) activator of Pup by deamidation and (b) recycler of Pup by depupylation. The function of Dop may not be limited to the Pup-proteasome pathway; as is the case with several deubiquitinases of the ubiquitin-proteasome system, Dop could serve a regulatory function within the cell, dictating protein localization or activity (40). Therefore, targeting Dop with small molecule inhibitors could interfere with a wide range of biochemical pathways in M. tuberculosis, and it is our hope that such inhibitors will provide a basis for the development of novel anti-tuberculosis compounds. To this end, we have developed a highly specific assay reagent to monitor Dop activity in a high throughput manner (41), and the data presented here will serve as a guide for the screening of inhibitors using this assay reagent.

Acknowledgments

We thank T. Begley, J. Belasco, J. Blanchard, A. Chatterjee, L. Hedstrom, T. Huang, R. Ledwidge, R. Qamra, C. Walsh, and K. Wilkinson for helpful discussions.

*

This work was supported, in whole or in part, by National Institutes of Health Grants 1R01AI088075 (to K. H. D) and GM67945 (to S. P. G.).

3
The abbreviations used are:
Pup
prokaryotic ubiquitin-like protein
Dop
deamidase of Pup
PafA
proteasome accessory factor A
DON
6-diazo-5-oxo-l-norleucine
HCD
higher energy C-trap dissociation
PTM
post-translational modification.

REFERENCES

  • 1. Pearce M. J., Mintseris J., Ferreyra J., Gygi S. P., Darwin K. H. (2008) Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis. Science 322, 1104–1107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Striebel F., Imkamp F., Sutter M., Steiner M., Mamedov A., Weber-Ban E. (2009) Bacterial ubiquitin-like modifier Pup is deamidated and conjugated to substrates by distinct but homologous enzymes. Nat. Struct. Mol. Biol. 16, 647–651 [DOI] [PubMed] [Google Scholar]
  • 3. Burns K. E., Darwin K. H. (2010) Pupylation versus ubiquitylation: tagging for proteasome-dependent degradation. Cell. Microbiol. 12, 424–431 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Wang T., Li H., Lin G., Tang C., Li D., Nathan C., Darwin K. H., Li H. (2009) Structural insights on the Mycobacterium tuberculosis proteasomal ATPase Mpa. Structure 17, 1377–1385 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Striebel F., Hunkeler M., Summer H., Weber-Ban E. (2010) The mycobacterial Mpa proteasome unfolds and degrades pupylated substrates by engaging Pup's N-terminus. EMBO J. 29, 1262–1271 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Hu G., Lin G., Wang M., Dick L., Xu R. M., Nathan C., Li H. (2006) Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate. Mol. Microbiol. 59, 1417–1428 [DOI] [PubMed] [Google Scholar]
  • 7. Imkamp F., Striebel F., Sutter M., Ozcelik D., Zimmermann N., Sander P., Weber-Ban E. (2010) Dop functions as a depupylase in the prokaryotic ubiquitin-like modification pathway. EMBO Rep. 11, 791–797 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Burns K. E., Cerda-Maira F. A., Wang T., Li H., Bishai W. R., Darwin K. H. (2010) “Depupylation” of prokaryotic ubiquitin-like protein from mycobacterial proteasome substrates. Mol. Cell 39, 821–827 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Cerda-Maira F. A., Pearce M. J., Fuortes M., Bishai W. R., Hubbard S. R., Darwin. K. H. (2010) Molecular analysis of the prokaryotic ubiquitin-like protein (Pup) conjugation pathway in Mycobacterium tuberculosis. Mol. Microbiol. 77, 1123–1135 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Darwin K. H. (2009) Prokaryotic ubiquitin-like protein (Pup), proteasomes, and pathogenesis. Nat. Rev. Microbiol. 7, 485–491 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Iyer L. M., Burroughs A. M., Aravind L. (2008) Unraveling the biochemistry and provenance of pupylation: a prokaryotic analog of ubiquitination. Biol. Direct 3, 45–51 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Guth E., Thommen M., Weber-Ban E. (2011) Mycobacterial ubiquitin-like protein ligase PafA follows a two-step reaction pathway with a phosphorylated Pup intermediate. J. Biol. Chem. 286, 4412–4419 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Hatfull G. F., Jacobs W. R. (2000) Molecular Genetics of Mycobacteria, ASM Press, Washington, D. C [Google Scholar]
  • 14. Burns K. E., Liu W. T., Boshoff H. I., Dorrestein P. C., Barry C. E., 3rd (2009) Proteasomal protein degradation in mycobacteria is dependent upon a prokaryotic ubiquitin-like protein. J. Biol. Chem. 284, 3069–3075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Noens E. E., Williams C., Anandhakrishnan M., Poulsen C., Ehebauer M. T., Wilmanns M. (2011) Improved mycobacterial protein production using a Mycobacterium smegmatis groEL1ΔC expression strain. BMC Biotechnol. 11, 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Li J., Gao X., Joss L., Rechsteiner M. (2000) The proteasome activator 11 S REG or PA28: chimeras implicate carboxyl-terminal sequences in oligomerization and proteasome binding but not in the activation of specific proteasome catalytic subunits. J. Mol. Biol. 299, 641–654 [DOI] [PubMed] [Google Scholar]
  • 17. Rappsilber J., Ishihama Y., Mann M. (2003) Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663–670 [DOI] [PubMed] [Google Scholar]
  • 18. Huttlin E. L., Jedrychowski M. P., Elias J. E., Goswami T., Rad R., Beausoleil S. A., Villen J., Haas W., Sowa M. E., Gygi S. P. (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174–1189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Wilkinson K. D., Gan-Erdene T., Kolli N. (2005) Derivitization of the C-terminus of ubiquitin and ubiquitin-like proteins using intein chemistry: methods and uses. Methods Enzymol. 399, 37–51 [DOI] [PubMed] [Google Scholar]
  • 20. Borodovsky A., Ovaa H., Kolli N., Gan-Erdene T., Wilkinson K. D., Ploegh H. L., Kessler B. M. (2002) Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol. 9, 1149–1159 [DOI] [PubMed] [Google Scholar]
  • 21. Dion H. W., Fusari S. A., Jakubowski Z. L., Zora J. G., Bartz Q. R. (1956) 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance: II. isolation and characterization. J. Am. Chem. Soc. 78, 3075–3077 [Google Scholar]
  • 22. Ortlund E., Lacount M. W., Lewinski K., Lebioda L. (2000) Reactions of Pseudomonas 7A glutaminase-asparaginase with diazo analogues of glutamine and asparagine result in unexpected covalent inhibitions and suggests an unusual catalytic triad Thr-Tyr-Glu. Biochemistry 39, 1199–1204 [DOI] [PubMed] [Google Scholar]
  • 23. Kaartinen V., Williams J. C., Tomich J., Yates J. R., 3rd, Hood L. E., Mononen I. (1991) Glycosaparaginase from human leukocytes: inactivation and covalent modification with diazo-oxonorvaline. J. Biol. Chem. 266, 5860–5869 [PubMed] [Google Scholar]
  • 24. Lehmann C., Doseeva V., Pullalarevu S., Krajewski W., Howard A., Herzberg O. (2004) YbdK is a carboxylate-amine ligase with a γ-glutamyl:cysteine ligase activity: crystal structure and enzymatic assays. Proteins 56, 376–383 [DOI] [PubMed] [Google Scholar]
  • 25. Imkamp F., Rosenberger T., Striebel F., Keller P. M., Amstutz B., Sander P., Weber-Ban E. (2010) Deletion of Dop in Mycobacterium smegmatis abolishes pupylation of protein substrates in vivo. Mol. Microbiol. 75, 744–754 [DOI] [PubMed] [Google Scholar]
  • 26. Liu J. Q., Kurihara T., Miyagi M., Tsunasawa S., Nishihara M., Esaki N., Soda K. (1997) Paracatalytic inactivation of L-2-haloacid dehalogenase from Pseudomonas sp. YL by hydroxylamine: evidence for the formation of an ester intermediate. J. Biol. Chem. 272, 3363–3368 [DOI] [PubMed] [Google Scholar]
  • 27. Stelte B., Witzel H. (1986) Formation of an aspartyl phosphate intermediate in the reactions of nucleoside phosphotransferase from carrots. Eur. J. Biochem. 155, 121–124 [DOI] [PubMed] [Google Scholar]
  • 28. Lipmann F., Tuttle L. C. (1945) The detection of activated carboxyl groups with hydroxylamine as interceptor. J. Biol. Chem. 161, 415–416 [PubMed] [Google Scholar]
  • 29. Shapir N., Sadowsky M. J., Wackett L. P. (2005) Purification and characterization of allophanate hydrolase (AtzF) from Pseudomonas sp. strain ADP, J. Bacteriol. 187, 3731–3738 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Jencks W. P. (1958) The reaction of hydroxylamine with activated acyl groups: I. formation of O-acylhydroxylamine. J. Am. Chem. Soc. 80, 4581–4584 [Google Scholar]
  • 31. Zhang M., Liu J., Kim Y., Dixon J. E., Pfaff S. L., Gill G. N., Noel J. P., Zhang Y. (2010) Structural and functional analysis of the phosphoryl transfer reaction mediated by the human small C-terminal domain phosphatase, Scp1. Protein Sci. 19, 974–986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Crooks G. P., Xu L., Barkley R. M., Copley S. D. (1995) Exploration of possible mechanisms for 4-chlorobenzoyl CoA dehalogenase: evidence for an aryl-enzyme intermediate. J. Am. Chem. Soc. 117, 10791–10798 [Google Scholar]
  • 33. Rye C. S., Withers S. G. (2000) Glycosidase mechanisms. Curr. Opin. Chem. Biol. 4, 573–580 [DOI] [PubMed] [Google Scholar]
  • 34. Sander M. E., Witzel H. (1985) Direct chemical evidence for the mixed anhydride intermediate of carboxypeptidase A in ester and peptide hydrolysis. Biochem. Biophys. Res. Commun. 132, 681–687 [DOI] [PubMed] [Google Scholar]
  • 35. Kaiser B. L., Kaiser E. T. (1969) Effect of D2O on the carboxypeptidase-catalyzed hydrolysis of O-(trans-cinnamoyl)-L-β-phenyllactate and N-(N-benzoylglycyl)-L-phenylalanine. Proc. Natl. Acad. Sci. U.S.A. 64, 36–41 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Lee H. C., Ko Y. H., Baek S. B., Kim D. H. (1998) Detection of an anhydride intermediate in the carboxypeptidase A-catalyzed hydrolysis of a peptide substrate by solid state NMR spectroscopy and its mechanistic implication. Bioorg. Med. Chem. Lett. 8, 3379–3384 [DOI] [PubMed] [Google Scholar]
  • 37. Breslow R., Chin J., Hilvert D., Trainor G. (1983) Evidence for the general base mechanism in carboxypeptidase A-catalyzed reactions: partitioning studies on nucleophiles and H218O kinetic isotope effects. Proc. Natl. Acad. Sci. U.S.A. 80, 4585–4589 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Breslow R., Wernick D. L. (1977) Unified picture of mechanisms of catalysis by carboxypeptidase A. Proc. Natl. Acad. Sci. U.S.A. 74, 1303–1307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Kuo L. C., Fukuyama J. M., Makinen M. W. (1983) Catalytic conformation of carboxypeptidase A: the structure of a true reaction intermediate stabilized at subzero temperatures. J. Mol. Biol. 163, 63–105 [DOI] [PubMed] [Google Scholar]
  • 40. Delley C. L., Striebel F., Heydenreich F. M., Özcelik D., Weber-Ban E. (2012) Activity of the mycobacterial proteasomal ATPase Mpa is reversibly regulated by pupylation. J. Biol. Chem. 287, 7907–7914 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Merkx R., Burns K. E., Slobbe P., El Oualid F., El Atmioui D., Darwin K. H., Ovaa H. (2012) Synthesis and evaluation of a selective fluorogenic Pup-derived assay reagent for Dop, a potential drug target in Mycobacterium tuberculosis. ChemBioChem, 13, 2056–2060 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES